Lv11
40 积分 2024-10-31 加入
Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay)
2小时前
待确认
Advances in Development of Selective Antitumor Inhibitors That Target PARP-1
5天前
已完结
First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase 1 dose exploration
12天前
已完结
Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases
12天前
已完结
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1–DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs
14天前
已完结
Recent advances and future strategies in first-line treatment of ES-SCLC
22天前
已完结
皖公网安备34019202002308
